• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高肝胆恶性肿瘤重大切除术的安全性:门静脉栓塞术和肝脏再生策略的最新创新。

Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies.

机构信息

Department of Radiology and Biomedical Imaging, Section of Interventional Radiology, Yale School of Medicine, New Haven, CT, USA.

Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Curr Oncol Rep. 2020 May 16;22(6):59. doi: 10.1007/s11912-020-00922-x.

DOI:10.1007/s11912-020-00922-x
PMID:32415401
Abstract

PURPOSE OF REVIEW

For three decades, portal vein embolization (PVE) has been the "gold-standard" strategy to hypertrophy the anticipated future liver remnant (FLR) in advance of major hepatectomy. During this time, CT volumetry was the most common method to preoperatively assess FLR quality and function and used to determine which patients are appropriate surgical candidates. This review provides the most up-to-date methods for preoperatively assessing the anticipated FLR and summarizes data from the currently available strategies used to induce FLR hypertrophy before surgery for hepatobiliary malignancy.

RECENT FINDINGS

Functional and physiological imaging is increasingly replacing standard CT volumetry as the method of choice for preoperative FLR assessment. PVE, associating liver partition and portal vein ligation, radiation lobectomy, and liver venous deprivation are all currently available techniques to hypertrophy the FLR. Each strategy has pros and cons based on tumor type, extent of resection, presence or absence of underlying liver disease, age, performance status, complication rates, and other factors. Numerous strategies can lead to FLR hypertrophy and improve the safety of major hepatectomy. Which is best has yet to be determined.

摘要

目的综述

三十年来,门静脉栓塞术(PVE)一直是在进行大肝切除术前使预期未来肝残留量(FLR)增生的“金标准”策略。在此期间,CT 体积测量是最常用的术前评估 FLR 质量和功能的方法,并用于确定哪些患者适合手术。本综述提供了最新的方法来术前评估预期的 FLR,并总结了目前用于肝胆恶性肿瘤术前诱导 FLR 增生的可用策略的数据。

最新发现

功能和生理成像正逐渐取代标准 CT 体积测量,成为术前 FLR 评估的首选方法。PVE、联合肝脏分割和门静脉结扎、放射叶切除术和肝静脉剥夺都是目前可用于使 FLR 增生的技术。每种策略都基于肿瘤类型、切除范围、是否存在潜在的肝脏疾病、年龄、身体状况、并发症发生率和其他因素而具有优缺点。许多策略可以导致 FLR 增生并提高大肝切除术的安全性。哪种方法最好尚未确定。

相似文献

1
Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies.提高肝胆恶性肿瘤重大切除术的安全性:门静脉栓塞术和肝脏再生策略的最新创新。
Curr Oncol Rep. 2020 May 16;22(6):59. doi: 10.1007/s11912-020-00922-x.
2
Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.同期门静脉和肝静脉栓塞术优于门静脉栓塞术或 ALPPS 用于大肝切除术前未来肝残存量的代偿性增生:系统评价和网络荟萃分析。
Hepatobiliary Pancreat Dis Int. 2023 Jun;22(3):221-227. doi: 10.1016/j.hbpd.2022.08.013. Epub 2022 Sep 7.
3
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.HYPER-LIV01 试验方案:一项多中心、前瞻性、随机对照研究,比较同时门静脉和肝静脉栓塞与门静脉栓塞在结直肠肝转移行大范围肝切除前对未来肝残留量的肝体积增大的效果。
BMC Cancer. 2020 Jun 19;20(1):574. doi: 10.1186/s12885-020-07065-z.
4
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.联合肝脏离断和门静脉结扎的分阶段肝切除术(ALPPS):一种增加肝脏手术可切除性的新策略。
Int J Surg. 2014;12(5):437-41. doi: 10.1016/j.ijsu.2014.03.009. Epub 2014 Apr 2.
5
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients.肝细胞癌患者门静脉栓塞、联合肝脏分隔和门静脉结扎以及放射性肝叶切除术结果的系统评价和荟萃分析
Curr Oncol Rep. 2021 Oct 30;23(11):135. doi: 10.1007/s11912-021-01075-1.
6
Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS.门静脉栓塞后经皮微波消融肝内分割术(PISA)促进未来肝残余体积增大的可行性:放射学1期ALPPS。
Cardiovasc Intervent Radiol. 2018 May;41(5):789-798. doi: 10.1007/s00270-018-1882-7. Epub 2018 Jan 22.
7
Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy: A Better Way to Optimize Liver Hypertrophy Compared to Portal Vein Embolization.放射学同步门腔静脉栓塞术(RASPE)在肝切除术之前:与门静脉栓塞术相比,优化肝脏肥大的更好方法。
Ann Surg. 2020 Aug;272(2):199-205. doi: 10.1097/SLA.0000000000003905.
8
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.经肝同侧右门静脉栓塞扩展至IV段:使用球形颗粒和线圈改善肥大及切除效果
J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):215-25. doi: 10.1097/01.RVI.0000147067.79223.85.
9
Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy.右门静脉栓塞术联合绝对乙醇在肝胆恶性肿瘤肝切除术中的应用。
Br J Surg. 2014 Aug;101(9):1122-8. doi: 10.1002/bjs.9541. Epub 2014 Jun 11.
10
Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients.用聚乙烯醇颗粒和弹簧圈进行门静脉栓塞以准备行肝胆恶性肿瘤的大肝切除术:安全性和有效性——26例患者的研究
Radiology. 2003 Apr;227(1):251-60. doi: 10.1148/radiol.2271012010. Epub 2003 Feb 28.

引用本文的文献

1
Modelling the liver's regenerative capacity across different clinical conditions.模拟不同临床情况下肝脏的再生能力。
JHEP Rep. 2025 May 30;7(8):101465. doi: 10.1016/j.jhepr.2025.101465. eCollection 2025 Aug.
2
Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta-Analysis.术前肝脏增大术与经动脉化疗栓塞术治疗残余肝体积不足的肝细胞癌:一项系统评价和荟萃分析
Cancer Med. 2025 Jul;14(13):e71050. doi: 10.1002/cam4.71050.
3
MicroRNA based Prediction of Posthepatectomy Liver Failure and Mortality Outperforms Established Markers of Preoperative Risk Assessment.
基于微小RNA预测肝切除术后肝衰竭和死亡率优于术前风险评估的既定标志物。
Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17528-x.
4
Predictive value of intra-hepatectomy ICGR15 of the remnant liver for post-hepatectomy liver failure in hemi-hepatectomy: a prospective study.半肝切除术中残余肝内肝切除ICGR15对肝切除术后肝衰竭的预测价值:一项前瞻性研究
BMC Cancer. 2025 May 16;25(1):881. doi: 10.1186/s12885-025-14296-5.
5
New Imaging Techniques.新成像技术。
Recent Results Cancer Res. 2023;219:109-145. doi: 10.1007/978-3-031-35166-2_6.
6
Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery.使用个体化剂量测定法经钇-90治疗后降期的大肝癌、多灶性肝癌或侵犯门静脉的肝细胞癌(HCC):安全性、病理结果及术后结局
Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):351-365. doi: 10.21037/hbsn-22-184. Epub 2022 Oct 31.
7
Volume and flow modulation strategies to mitigate post-hepatectomy liver failure.减轻肝切除术后肝衰竭的容量和血流调节策略。
Front Oncol. 2022 Nov 17;12:1021018. doi: 10.3389/fonc.2022.1021018. eCollection 2022.
8
Predictors of Liver Failure in Non-Cirrhotic Patients Undergoing Hepatectomy.非肝硬化患者行肝切除术的肝衰竭预测因素。
World J Surg. 2022 Dec;46(12):3081-3089. doi: 10.1007/s00268-022-06742-3. Epub 2022 Oct 8.
9
Current trends in regenerative liver surgery: Novel clinical strategies and experimental approaches.再生肝脏手术的当前趋势:新型临床策略与实验方法。
Front Surg. 2022 Sep 7;9:903825. doi: 10.3389/fsurg.2022.903825. eCollection 2022.
10
MMP2/9 downregulation is responsible for hepatic function recovery in cirrhotic rats following associating liver partition and portal vein ligation for staged hepatectomy.基质金属蛋白酶2/9的下调负责在联合肝脏分隔和门静脉结扎分期肝切除术后肝硬化大鼠肝功能的恢复。
Ann Transl Med. 2022 Apr;10(8):468. doi: 10.21037/atm-22-1312.